← Leaderboards
Jeremy James Johnson
University Of Illinois At Chicago
$2,654,168
Attributed
$2,654,168
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $371.7K · FY2009–25$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,654,168 · 2
By mechanism
R37$2,501,418 · 1
R03$152,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Dolly Mehta$25,727,046
Others in their field
Top investigators on “Property”
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
PropertyAnimal ModelIn VitroXanthonesMalignant Neoplasm Of ProstateCancer ChemopreventionFutureGarcinia MangostanaPharmaceutical PreparationsSmall MoleculePhosphotransferasesDrug KineticsDoseIn VivoChemopreventionFruitDimerizationAndrogen AntagonistsEndoplasmic Reticulum StressEstrogen AntagonistsFosteringCastrationAndrogen ReceptorBinding
Grant awards (9)
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer$371,679
R37 · FY2025 · CA · contact PI
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer$371,677
R37 · FY2024 · CA · contact PI
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer$346,361
R37 · FY2023 · CA · contact PI
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer$353,430
R37 · FY2022 · CA · contact PI
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer$353,431
R37 · FY2021 · CA · contact PI
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer$352,420
R37 · FY2020 · CA · contact PI
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer$352,420
R37 · FY2019 · CA · contact PI
Mangostin: A Dietary-Based Xanthone For Prostate Cancer Chemoprevention$78,500
R03 · FY2010 · CA · contact PI
Mangostin: A Dietary-Based Xanthone For Prostate Cancer Chemoprevention$74,250
R03 · FY2009 · CA · contact PI